E. Berns
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
-
- Cancer Genomics and Diagnostics 9
- Breast Cancer Treatment Studies 3
- Oncology 16
- Cancer-related Molecular Pathways 9
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 3
- Co-authors
- John A. Foekens (13 shared papers)J.G.M. Klijn (13 shared papers)Iris L. van Staveren (8 shared papers)Henk Portengen (6 shared papers)S.C. Henzen‐Logmans (7 shared papers)J.G.M. Klijn (4 shared papers)Ignace Vergote (4 shared papers)Jozien Helleman (5 shared papers)
- Journals
- British Journal of Cancer (11 papers)Breast Cancer Research and Treatment (5 papers)European Journal of Cancer (3 papers)International Journal of Gynecological Cancer (2 papers)Annals of Oncology (2 papers)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
E. Berns
41 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 85
- Cancer Research 591
- Oncology 740
- Reproductive Medicine 214
- Genetics 383
- Molecular Biology 861
Countries citing papers authored by E. Berns
This map shows the geographic impact of E. Berns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Berns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Berns more than expected).
Fields of papers citing papers by E. Berns
This network shows the impact of papers produced by E. Berns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Berns. The network helps show where E. Berns may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Berns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 180 | |
| 2 | c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. | 1992 | 177 |
| 3 | 1997 | 175 | |
| 4 | Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. | 2000 | 162 |
| 5 | 2011 | 157 | |
| 6 | 2010 | 101 | |
| 7 | 2009 | 95 | |
| 8 | 1998 | 76 | |
| 9 | 2001 | 76 | |
| 10 | Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors. | 1992 | 70 |
| 11 | 2011 | 61 | |
| 12 | 2001 | 52 | |
| 13 | Prognostic factors and response to therapy in breast cancer. | 1993 | 51 |
| 14 | 1998 | 50 | |
| 15 | 2014 | 49 | |
| 16 | 2010 | 48 | |
| 17 | 2010 | 44 | |
| 18 | 1992 | 41 | |
| 19 | 2013 | 39 | |
| 20 | 2003 | 34 |
About E. Berns
E. Berns is a scholar working on Cancer Research, Oncology, Molecular Biology, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 41 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Cancer-related Molecular Pathways (9 papers), Ovarian cancer diagnosis and treatment (7 papers), HER2/EGFR in Cancer Research (5 papers), BRCA gene mutations in cancer (4 papers), Estrogen and related hormone effects (4 papers), Cancer Treatment and Pharmacology (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Cancer Research (591 citations), Oncology (740 citations), Reproductive Medicine (214 citations), Genetics (383 citations) and Molecular Biology (861 citations). E. Berns has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include John A. Foekens, J.G.M. Klijn, Iris L. van Staveren, Henk Portengen, S.C. Henzen‐Logmans, J.G.M. Klijn, Ignace Vergote, Jozien Helleman, Maxime P. Look and Peter A. van Dam. Their work appears in journals such as British Journal of Cancer, Breast Cancer Research and Treatment, European Journal of Cancer, International Journal of Gynecological Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.